US healthcare policy is undergoing rapid change, with wide-ranging consequences for biopharma strategy, pricing and competitiveness. From government efforts to control drug costs to shifts in vaccine policy and pharmacy benefit manager (PBM) reform, manufacturers face a complex and evolving policy landscape. At the same time, evolving trade policies have created a climate of uncertainty for biopharma companies, making it difficult to manage supply chains and make long-term plans.
In this webinar, the featured speakers will break down the policy developments that matter most for biopharma leaders; what’s changing, how it may impact the industry and the strategies companies are deploying to adapt.
Register for this webinar to learn how the changing regulatory landscape is reshaping biopharma strategy and market dynamics.
Speakers
Sara Mallatt, Director of Healthcare Research, AlphaSense
Sara has almost 20 years of experience generating sell-side research content across various industries. Before joining AlphaSense, Sara held leadership positions at OTR Global, a leading channel research firm, most recently as Director of Healthcare Research. Sara earned a Bachelor’s degree in Journalism and a Master’s degree in Industrial Engineering.
Message Presenter
Dr. Robert Popovian, Vice President, Health Economics and Policy, Equideum Health
Dr. Robert Popovian is the Founder of the strategic consulting firm Conquest Advisors. He also serves as the Chief Science Policy Officer at the Global Healthy Living Foundation, a Senior Healthy Policy Fellow at the Progressive Policy Institute and a Visiting Health Policy Fellow at the Pioneer Institute. He is one of the country’s foremost experts on every significant facet of biopharmaceuticals and the healthcare industry. He is a recognized authority on drug pricing, spending, affordability and access policy and political issues.
Message PresenterWho Should Attend?
This webinar will appeal to professionals in the following fields:
- Business Development
- Analyst Relations
- Competitive Intelligence
- Corporate Development
- Corporate Strategy
- Investment
- Market Intelligence
- Market Insight
- Market Research
- Mergers & Acquisitions (M&A)
- Strategic Planning
- Business Operations
What You Will Learn
Attendees will:
- Understand how government cost-control measures are reshaping pricing strategies for manufacturers
- Explore the latest changes in coverage and distribution policies and what they mean for biopharma
- Learn how evolving regulations may alter reimbursement dynamics and market access
- Assess how global policy uncertainty is disrupting supply chains and long-term planning
Xtalks Partner
AlphaSense
AlphaSense is the AI platform redefining market intelligence and workflow orchestration, trusted by thousands of leading organizations to drive faster, more confident decisions in business and finance. The platform combines domain specific AI with a vast content universe of over 500 million premium business documents — including equity research, earnings calls, expert interviews, filings, news, and internal proprietary content. Purpose-built for speed, accuracy, and enterprise-grade security, AlphaSense helps teams extract critical insights, uncover market-moving trends, and automate complex workflows with high quality outputs. With AI solutions like Generative Search, Generative Grid, and Deep Research, AlphaSense delivers the clarity and depth professionals need to navigate complexity and obtain accurate, real-time information quickly. For more information, visit www.alpha-sense.com.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account